International
Early analysis of Pfizer shows 90% efficacy
Kathmandu. The manufacturer of the vaccine against the novel coronavirus, Pfizer has claimed that they have achieved an effectiveness of more than 90%, in early analysis. CNN reported that the so-called interim analysis looked at the first 94 confirmed cases of COVID-19 among more than 43,000 volunteers who got either two doses of the vaccine
No ads found for this position
Trending News
- This Week
- This Month
